Skip to main content
Clinical Trials/NCT00502918
NCT00502918
Terminated
N/A

Feasibility Study -Clinical Feasibility of Computerized Labor Monitor (CLM) -Heart Application

Barnev Ltd1 site in 1 country3 target enrollmentFebruary 2008
ConditionsObstetricsLabor

Overview

Phase
N/A
Intervention
Not specified
Conditions
Obstetrics
Sponsor
Barnev Ltd
Enrollment
3
Locations
1
Primary Endpoint
Monitoring fetal heart movement
Status
Terminated
Last Updated
16 years ago

Overview

Brief Summary

The study is a feasibility study to check the possibility of tracking the heart rate of the fetus and to translate the outcome to the progress of the labor

Detailed Description

Every year, millions of babies are born worldwide. Yet, despite great advances in medical technology, the method used to obtain the most critical parameter in labor management - cervix dilatation, remains a vaginal (manual) examination. This vaginal examination, intended to estimate the dilatation of the cervix and the progress of the baby's head, is inaccurate, non-continuous and involves the risk of infection to both fetus and mother. It is also uncomfortable to the mother. The consequences of infections or delayed treatment may range from simple complications to irreversible damage. Early detection of abnormal patterns of labor progress could prevent complications and shorten the labor process and hospitalization, thereby saving both aggravation and cost. To truly manage the labor process, a labor management system is required. Such a system is expected to provide the obstetrical staff with the flow of accurate, continuous, real-time information, such as cervix dilatation.

Registry
clinicaltrials.gov
Start Date
February 2008
End Date
August 2008
Last Updated
16 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Barnev Ltd

Eligibility Criteria

Inclusion Criteria

  • Laboring women refered to the maternity center in active labor (3cm dilatation and contraction)
  • Gestational age 37-42 weeks. (GA)
  • Single Fetus.
  • Subjects who understand, agreed and signed the informed consent form.

Exclusion Criteria

  • Women with abnormal placentation (Placenta previa) -
  • Abnormal fetal presentation (Breech presentation).
  • Maternal History of HIV and/or blood transmitted Hepatitis and /or active genital Herpes.
  • Need for immediate delivery (cord prolapsed or suspected placental abruption)

Outcomes

Primary Outcomes

Monitoring fetal heart movement

Time Frame: During labour

Study Sites (1)

Loading locations...

Similar Trials